Foundry Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,079
Closed -$419K 325
2024
Q2
$419K Sell
6,079
-58
-0.9% -$3.93K 0.02% 252
2024
Q1
$445K Sell
6,137
-1,330
-18% -$88.9K 0.02% 226
2023
Q4
$457K Hold
7,467
0.03% 232
2023
Q3
$427K Sell
7,467
-1,405
-16% -$84.9K 0.03% 235
2023
Q2
$527K Buy
8,872
+320
+4% +$19.1K 0.03% 237
2023
Q1
$536K Buy
8,552
+114
+1% +$7.12K 0.03% 233
2022
Q4
$528K Buy
8,438
+1,378
+20% +$79K 0.03% 226
2022
Q3
$352K Sell
7,060
-575
-8% -$31.8K 0.02% 260
2022
Q2
$449K Buy
7,635
+2,610
+52% +$144K 0.03% 245
2022
Q1
$266K Sell
5,025
-149,888
-97% -$8.65M 0.01% 315
2021
Q4
$9.39M Sell
154,913
-14,692
-9% -$872K 0.33% 118
2021
Q3
$9.52M Buy
+169,605
New +$9.31M 0.34% 119
2021
Q1
Sell
-7,175
Closed -$250K 445
2020
Q4
$250K Buy
7,175
+800
+13% +$28.4K 0.01% 400
2020
Q3
$232K Buy
+6,375
New +$237K 0.01% 393
2020
Q2
Sell
-10,999
Closed -$403K 408
2020
Q1
$403K Sell
10,999
-535
-5% -$20.8K 0.02% 345
2019
Q4
$467K Buy
11,534
+49
+0.4% +$1.83K 0.02% 352
2019
Q3
$398K Sell
11,485
-225
-2% -$7.41K 0.02% 355
2019
Q2
$371K Buy
11,710
+2,060
+21% +$61.2K 0.01% 358
2019
Q1
$289K Buy
+9,650
New +$277K 0.01% 370

Other funds holding PBH

Foundry Partners's PBH Position: Q3 2024 in Review

Foundry Partners sold out of Prestige Consumer Healthcare (PBH) in Q3 2024, closing a stake of 6,079 shares — an estimated $419K sold.

Foundry Partners first reported a position in PBH in Q1 2019 and held it in 19 quarters. The position peaked at $9.52M in Q3 2021. 328 funds tracked by Wall St. Rank hold PBH as of Q3 2024.

  • Foundry Partners reported no remaining Prestige Consumer Healthcare position as of Q3 2024 after selling out during the quarter.
  • Foundry Partners sold 6,079 Prestige Consumer Healthcare shares in Q3 2024, an estimated $419K.
  • Foundry Partners first reported a position in Prestige Consumer Healthcare in Q1 2019 and held it in 19 quarters.
  • Foundry Partners's Prestige Consumer Healthcare position peaked at $9.52M in Q3 2021.
  • 328 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2024.

Based on Foundry Partners's 13F filing for Q3 2024, filed 8 Nov 2024.